Key Segments:
By Product
-
Heart valve devices
-
Annuloplasty rings
-
Occluders and delivery systems
-
Other products
By Procedure
-
Replacement procedures
-
Repair procedures
By End Use
-
Hospitals
-
Ambulatory surgical centers
-
Cardiac catheterization labs
-
Other end use
Regional Coverage:
North America
-
US
-
Canada
Europe
-
Germany
-
France
-
UK
-
Italy
-
Spain
-
Poland
-
Russia
-
Rest of Europe
Asia Pacific
-
China
-
India
-
Japan
-
South Korea
-
Australia
-
ASEAN Countries
-
Rest of Asia Pacific
Middle East & Africa
-
UAE
-
Saudi Arabia
-
Qatar
-
South Africa
-
Rest of Middle East & Africa
Latin America
-
Brazil
-
Argentina
-
Mexico
-
Colombia
-
Rest of Latin America
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
-
Detailed Volume Analysis
-
Criss-Cross segment analysis (e.g. Product X Application)
-
Competitive Product Benchmarking
-
Geographic Analysis
-
Additional countries in any of the regions
-
Customized Data Representation
-
Detailed analysis and profiling of additional market players
Frequently Asked Questions
Key players include Edwards Lifesciences, Medtronic, Abbott, Boston Scientific, Johnson & Johnson MedTech, LivaNova, Artivion, and Meril Life Sciences.
Key opportunities include repair procedure expansion, transseptal delivery innovation, emerging-market cath lab infrastructure development, and multi-valve program adoption.
The market is driven by rising structural heart disease prevalence, transcatheter procedure adoption, regulatory eligibility expansion, and cath lab infrastructure investment.
The Heart valve devices segment dominated the Structural Heart Devices Market, accounting for approximately 64% market share.
The North America region dominated the Structural Heart Devices Market in 2025 with approximately 44.0% share, driven by advanced infrastructure and high disease prevalence.
